<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Editas_Medicine%2C_Inc.</id>
	<title>Editas Medicine, Inc. - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Editas_Medicine%2C_Inc."/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Editas_Medicine,_Inc.&amp;action=history"/>
	<updated>2026-05-20T13:07:28Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Editas_Medicine,_Inc.&amp;diff=417507&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Editas Medicine, Inc. listata cu simbolul US.EDIT  ==Descriere companie== Editas Medicine, Inc. (www.editasmedicine.com) is a clinical-stage gene editing company. The Company is focused on developing transformative gene-editing medicines to treat a range of serious diseases. It operates through the developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly interspaced sho...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Editas_Medicine,_Inc.&amp;diff=417507&amp;oldid=prev"/>
		<updated>2024-09-18T17:52:30Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Editas Medicine, Inc. listata cu simbolul US.EDIT  ==Descriere companie== Editas Medicine, Inc. (www.editasmedicine.com) is a clinical-stage gene editing company. The Company is focused on developing transformative gene-editing medicines to treat a range of serious diseases. It operates through the developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly interspaced sho...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Editas Medicine, Inc. listata cu simbolul US.EDIT&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Editas Medicine, Inc. (www.editasmedicine.com) is a clinical-stage gene editing company. The Company is focused on developing transformative gene-editing medicines to treat a range of serious diseases. It operates through the developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The Company is focused on both in vivo gene-editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body and ex vivo gene-edited cell medicines, in which cells are edited with its technology.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.EDIT&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Editas Medicine, Inc. (US.EDIT)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.EDIT&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.EDIT]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>